Dexcom Recalls G7 Glucose Receiver Over Faulty Speaker Alert

Dexcom, Inc. has initiated a Class I recall, the most serious type issued by the FDA, for its G7 Continuous Glucose Monitoring System Receiver due to a manufacturing defect that may cause its speaker to stop functioning. Without audible alerts, users may not be notified of dangerously high or low blood glucose levels, risking severe health consequences.

The Risk at Hand

The speaker may become disconnected from the receiver's circuit board due to faulty internal foam or improper assembly. If the speaker fails, the receiver won't emit critical alarms, even when blood sugar reaches life-threatening levels.

This defect could lead to:

• Severe hypoglycemia or hyperglycemia
• Seizures, loss of consciousness
• Potential death in worst-case scenario

What Products Are Affected?

The recall affects 602,445 units distributed globally, including across the United States, Europe, Canada, and Australia. Product identifiers include but are not limited to:

• STK-AT-011
• STK-GT-001
• STK-GT-008
• STK-GT-100

You can verify your device using the FDA's product recall page.

What Dexcom Users Should Do

Dexcom is offering free replacements. Here's how to protect yourself:

1. Test your speaker each time the receiver is charged.
2. Visit Dexcom’s recall site and enter your receiver serial number.
3. Contact Dexcom Technical Support at 1-844-478-1600 for next steps.

Dexcom G7 Recall Lawsuit: Know Your Rights

Patients harmed by defective glucose monitoring devices may be entitled to compensation. If you or a loved one suffered due to Dexcom’s G7 Receiver defect, you may have a case. Our attorneys are investigating claims now and helping patients hold manufacturers accountable.

If these recalled products have caused you or a loved one injury, you may be entitled to compensation. Take action and contact Morgan & Morgan today for a free, no-obligation case evaluation.